These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 21154139)

  • 21. Target Discovery--Select Biosciences' World Congress. 4-5 August 2009, San Francisco, CA, USA.
    Fernández A
    IDrugs; 2009 Oct; 12(10):620-2. PubMed ID: 19790009
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ocular Diseases & Drug Discovery--GTCbio's Inaugural Conference. 20-21 April 2009, Philadelphia, PA, USA.
    Boniuk V
    IDrugs; 2009 Jun; 12(6):346-8. PubMed ID: 19517312
    [No Abstract]   [Full Text] [Related]  

  • 23. World Vaccine Congress Lyon - Terrapinn's 11th Annual Congress.
    Sovran L
    IDrugs; 2009 Dec; 12(12):738-41. PubMed ID: 19943212
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cancer vaccines for non-small-cell lung cancer.
    Palma M; Choudhury A; Mellstedt H
    Minerva Chir; 2009 Dec; 64(6):643-53. PubMed ID: 20029360
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In silico methods for design of biological therapeutics.
    Roy A; Nair S; Sen N; Soni N; Madhusudhan MS
    Methods; 2017 Dec; 131():33-65. PubMed ID: 28958951
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Drug Development for Neurodegenerative Diseases--Second Annual marcus evans Conference. Advances in drug development for NDD and expediting discovery through novel compounds and sound clinical trials.
    Morimoto B
    IDrugs; 2010 Jul; 13(7):440-3. PubMed ID: 20582866
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Molecular Diagnostics--Select Biosciences' Second World Congress. 6-7 August 2009, South San Francisco, CA, USA.
    Bodowitz S
    IDrugs; 2009 Oct; 12(10):627-8. PubMed ID: 19790011
    [TBL] [Abstract][Full Text] [Related]  

  • 28. 3rd Global Vaccine Congress.
    Kyd JM
    Expert Rev Vaccines; 2010 Jan; 9(1):13-7. PubMed ID: 20021300
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The role of natural products in drug discovery and development in the new millennium.
    Harvey A
    IDrugs; 2010 Feb; 13(2):70-2. PubMed ID: 20127553
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Enhanced anti-tumor therapeutic efficacy of DNA vaccine by fusing the E7 gene to BAFF in treating human papillomavirus-associated cancer.
    Wu CC; Wu FC; Hsu YT; Hsiao YC; Yang YC; Chang CA; Chang CL
    Oncotarget; 2017 May; 8(20):33024-33036. PubMed ID: 28423693
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Therapeutic cancer vaccines.
    Melief CJ; van Hall T; Arens R; Ossendorp F; van der Burg SH
    J Clin Invest; 2015 Sep; 125(9):3401-12. PubMed ID: 26214521
    [TBL] [Abstract][Full Text] [Related]  

  • 32. American Society of Clinical Oncology--46th annual meeting.
    Al-Shamahi A; Murch L; Kirkham K
    IDrugs; 2010 Aug; 13(8):506-9. PubMed ID: 20721815
    [TBL] [Abstract][Full Text] [Related]  

  • 33. DNA vaccines to attack cancer: Strategies for improving immunogenicity and efficacy.
    Tiptiri-Kourpeti A; Spyridopoulou K; Pappa A; Chlichlia K
    Pharmacol Ther; 2016 Sep; 165():32-49. PubMed ID: 27235391
    [TBL] [Abstract][Full Text] [Related]  

  • 34. DNA vaccination and gene therapy: optimization and delivery for cancer therapy.
    Bodles-Brakhop AM; Draghia-Akli R
    Expert Rev Vaccines; 2008 Sep; 7(7):1085-101. PubMed ID: 18767956
    [TBL] [Abstract][Full Text] [Related]  

  • 35. International society for antiviral research - 23rd international conference.
    Mason VL
    IDrugs; 2010 Jun; 13(6):363-5. PubMed ID: 20506054
    [TBL] [Abstract][Full Text] [Related]  

  • 36. HD Therapeutics - CHDI Fifth Annual Conference.
    Gagnon KT
    IDrugs; 2010 Apr; 13(4):219-23. PubMed ID: 20373247
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Personalized neoantigen vaccines: A new approach to cancer immunotherapy.
    Aldous AR; Dong JZ
    Bioorg Med Chem; 2018 Jun; 26(10):2842-2849. PubMed ID: 29111369
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunotherapy and lung cancer: current developments and novel targeted therapies.
    Domingues D; Turner A; Silva MD; Marques DS; Mellidez JC; Wannesson L; Mountzios G; de Mello RA
    Immunotherapy; 2014; 6(11):1221-35. PubMed ID: 25496336
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Are vaccines making a comeback in non-small-cell lung cancer?
    Nemunaitis JJ
    J Clin Oncol; 2008 Mar; 26(9):1402-3. PubMed ID: 18349390
    [No Abstract]   [Full Text] [Related]  

  • 40. IL-13 receptor-directed cancer vaccines and immunotherapy.
    Nakashima H; Husain SR; Puri RK
    Immunotherapy; 2012 Apr; 4(4):443-51. PubMed ID: 22512637
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.